← Back to Search

Behavioral Activation for Alcohol Use Disorder

Phase 2
Recruiting
Led By Tera L Fazzino, PhD
Research Sponsored by University of Kansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 months, 4 months, and 8 months; 17 months for participants in years 1-2
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new way to help college freshmen who drink too much alcohol. The intervention will address concerns that are most relevant to these students and be integrated into the college curriculum.

Who is the study for?
This trial is for college freshmen enrolled in UNIV 101 freshman seminar courses at the University of Kansas. It's designed to help students who are transitioning from high school to college and might be facing increased stress, which can lead to risky behaviors like heavy drinking or eating disorders.
What is being tested?
The study is testing a behavioral activation intervention integrated into the college curriculum. This approach aims to reduce alcohol use and related issues by focusing on concerns relevant to new college students rather than directly targeting alcohol consumption itself.
What are the potential side effects?
Since this is a behavioral intervention focused on activities and strategies within a classroom setting, traditional medical side effects are not applicable. However, participants may experience emotional discomfort when discussing personal issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 months, 4 months, and 8 months; 17 months for participants in years 1-2
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 months, 4 months, and 8 months; 17 months for participants in years 1-2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
alcohol consumption
alcohol-related problems
exceeding clinical cutoff of 8+ for hazardous/harmful drinking
+1 more
Secondary study objectives
binge eating
depression
stress
Other study objectives
alcohol violations on campus
coping-motivated drinking
delay discounting
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Activation CourseExperimental Treatment1 Intervention
Behavioral activation course condition administered in a college freshman orientation seminar
Group II: Standard Orientation CourseActive Control1 Intervention
Standard freshman orientation seminar course condition
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
behavioral activation
2016
N/A
~80

Find a Location

Who is running the clinical trial?

University of KansasLead Sponsor
154 Previous Clinical Trials
331,401 Total Patients Enrolled
1 Trials studying Depression
8 Patients Enrolled for Depression
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,108 Total Patients Enrolled
26 Trials studying Depression
7,636 Patients Enrolled for Depression
Tera L Fazzino, PhDPrincipal InvestigatorUniversity of Kansas

Media Library

Behavioral Activation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04038190 — Phase 2
Depression Research Study Groups: Standard Orientation Course, Behavioral Activation Course
Depression Clinical Trial 2023: Behavioral Activation Intervention Highlights & Side Effects. Trial Name: NCT04038190 — Phase 2
Behavioral Activation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04038190 — Phase 2
~47 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top